Market Cap N/A
Revenue (ttm) 34.16M
Net Income (ttm) -50.62M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,363
Avg Vol 56,854
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 85%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, Emeryville, United States
Latest News on OABIW
No data available.